NCT06995053 - Computed Tomography-Guided Stereotactic Body Radiation Therapy With Intrafraction Motion Monitoring for the Treatment of Localized Prostate Cancer, ILLUSION Trial | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

September 1, 2035

Study Completion Date

September 1, 2036

Conditions

Localized Prostate AdenocarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8Stage III Prostate Cancer AJCC v8

Interventions

PROCEDURE

Biospecimen Collection

Undergo blood sample collection

PROCEDURE

Computed Tomography

Undergo CT

RADIATION

CT-guided Stereotactic Body Radiation Therapy

Undergo CT-guided SBRT with intrafraction motion monitoring

OTHER

Intrafraction Motion Monitoring

Undergo CT-guided SBRT with intrafraction motion monitoring

PROCEDURE

Magnetic Resonance Imaging

Undergo MRI

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (1)

UCLA / Jonsson Comprehensive Cancer Center, Los Angeles